|
John was Managing Director and previously CEO of GroPep Ltd until 2002, positions he held since the inception of the company in 1988. From 1991 until 1999 he was also the CEO of the Cooperative Research Centre for Tissue Growth and Repair in which GroPep was a partner. He was the foundation Chairman of PrimeGRO Ltd from 1999 until 2002 and is currently a Director of Australian Orthopaedic Innovations Pty Ltd and Vice President of AusBiotech Ltd, the Australian biotechnology industry association. He is a biochemist by training (PhD, DSc), has authored more than 300 research publications and is an inventor of 10 patents. He was elected to the Australian Academy of Technological Sciences and Engineering in 1997.
Mark is a molecular cell biologist with ~70 publications and 18 years senior management experience driving cancer and inflammation discovery programs across industrial and clinical settings. His research interests include: advanced proteomic technologies, cancer metastasis and how proteases (their receptors, partners and inhibitors) regulate biological processes. His most recent work has focussed on the development of new biochip platforms (i.e., SELDI protein mapping strategies) for the early diagnosis of ovarian, breast and prostate cancer.
Mark is a council member of both Asia-Oceana Human Proteome Organisation (AO-HuPO) and HuPO.
Former positions include Director (Biomarker Discovery), LumiCyte, Fremont, CA, USA; Co-Director & Scientific Director, Gynaecological Cancer Research Centre, Royal Women's Hospital, Melbourne; Associate Professor, Biological Sciences, University of Wollongong; Research Fellow, John Curtin School of Medical Research, ANU; Post-doctoral Fellow, Biochemistry, Monash University.
Since graduating from Macquarie University - completing his BSc (Hons 1) and PhD in free radical biochemistry, Mark was awarded the International Society for Free Radical Research Young Investigator Award twice (1988 and 1990), the Howard Florey Medal in 1991 for cancer research he undertook whilst at ANU and the Neils Sträng Award, 1998 for studies undertaken on serine protease inhibitors.
- Prof Jim Piper (DVCR), Macquarie University
|